We have isolated cytotoxic T lymphocytes (CTL) preferentially reactive with the al external domain of the H-2Ld antigen by selecting for T cells capable of recognizing a variant major histocompatibility complex (MHC) class I antigen sharing al sequences with H-2Ld. Using these CTL, we demonstrate that a synthetic al peptide corresponding to one of the helices derived from the H-2Ld molecule can be presented by a class I restriction element to reconstitute a CTL determinant borne by intact H-2Ld. Moreover, several other H-2L-reactive CTL generated independently were also able to recognize H-2Ld either as an intact alloantigen or as a peptide in coiijunction with appropriate class I restriction elements. These data demonstrate that an H-2 peptide can reconstitute a CTL target structure and suggest that some alloreactive T cells in fact might be directed against allogeneic class I peptides in the context of a class I framework.
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The class I transplantation antigens, H-2K, H-2D, and H-2L, encoded within the major histocompatibility complex (MHC), are polymorphic cell-surface glycoproteins that play a central role in the regulation and function of the immune system (1, 2) . These molecules act as antigen-presentation structures or "restriction elements" directing the attack of cytotoxic T lymphocytes (CTL) against virally infected or nonself target cells. CTL generally show a requirement for the corecognition of foreign antigens in the context of specific self-MHC class I products (2, 3) . Therefore, CTL recognition is said to be "MHC-restricted." Although the precise mechanisms underlying MHC restriction remain obscure, recent results suggest that certain virus-specific CTL recognize virally derived, processed peptides in association with self-class I (4, 5). Similar mechanisms have been implicated in the class II MHC-restricted recognition of antigen by helper T cells (6) .
One of the most intriguing features of T-cell recognition is the phenomenon of alloreactivity. T-cell responses against allogeneic MHC antigens are extremely rapid and vigorous. Furthermore, many cloned, MHC-restricted, antigen-specific T cells exhibit crossreactivity with allo-MHC antigens. These observations suggest that both allo-and MHC-restricted recognition are mediated by the same basic mechanism (7, 8) . However, in neither case have all the MHC structural features recognized by the T cell been clearly defined. In particular, it is still not clear whether MHC molecules are recognized as independent structures by allospecific T cells or whether the relevant T-cell target structure consists of a complex between the allo-MHC molecule and some as yet unidentified cellular product or processed peptide (9) . Insight into this question comes from recent studies of CTL generated against mouse cell transfectants expressing HLA class I molecules (10, 11) . These studies suggest that some examples of allorecognition might involve the processing of the foreign class I antigens and their presentation in association with self-MHC products.
To determine whether the CTL recognition of allogeneic H-2 antigens might also proceed by an MHC-restricted mechanism, we examined the ability of C3H anti-H-2L alloreactive CTL to lyse C3H target cells in the presence of a synthetic peptide whose sequence was derived from the BALB/c H-2Ld molecule. We found that many of the H-2L-reactive CTL tested recognized an H-2Ld peptide in association with C3H H-2k restriction elements. Since these CTL also retain the capability of recognizing the H-2Ld antigen in the absence of H-2k restriction elements, these results suggest that the structure of the H-2L peptide in association with the H-2k restriction element resembles that presented by the intact H-2Ld molecule.
MATERIALS AND METHODS
Generation of CTL. C3H mice were immunized by i.p. injection of 107 1591 cells expressing the A149 antigen as well as the A216 and A166 antigens (12) . Spleens were harvested 4 weeks later, and a secondary culture of 1591 tumor-specific CTL was established by using mitomycin c-treated 1591 tumor cells in complete medium (RPMI 1640 medium containing 10o fetal calf serum and 1 ,M 2-mercaptoethanol). After 
RESULTS
Generation of H-2L-Reactive CTL. 1591 is a UV-induced C3H fibrosarcoma that expresses several class I epitopes not normally found on C3H tissue, in addition to normal H-2k products (15) . Previously, we cloned three class I genes from the 1591 genome whose products account for the expression of these apparently allogeneic epitopes and examined the recognition of these products by several CTL clones and viral-specific and alloreactive CTL cultures (12, 16) . One of these genes, H-2L'49 [previously referred to as A149 (12) H-2L 149 u-.n k highly homologous to the H-2Ld gene derived from BALB/c and encodes a distinct product that is recognized by a subset of H-2Ld-reactive CTL clones. In this report we refer to the product of this gene as H-2L149. The H-2L149 molecule is identical to the H-2Ld antigen in the al domain and differs by only six amino acid substitutions in the a2 domain ( Fig.  1) . Functionally, this product can be distinguished from H-2Ld by the lack of reactivity with two H-2Ld-reactive monoclonal antibodies and by its inability to serve as a target for several other H-2Ldspecific CTL clones (12) .
We attempted to generate a distinct set of H-2L-reactive CTL specific for the al domain of H-2Ld by taking advantage of the identity between H-2Ld and H-2L149 in this region. Briefly, spleen cells from 1591-immunized C3H mice were cultured in vitro in the presence of mitomycin c-treated 1591 tumor cells expressing H-2L149. After 1 week of growth in vitro, cultures were stimulated with C3H L cell transfectants expressing H-2Ld. Since CTL require specific antigenic stimulation to grow in the presence of interleukin 2-containing medium, only those cells reactive with the H-2Ld1 expressing stimulator cells would be expected to grow under these conditions. Consequently, stimulation of the anti-1591 CTL by H-2Ld transfectants might enrich for CTL that preferentially recognize structural features shared between the H-2L149 and H-2Ld products-namely, CTL epitopes encoded within the al domain. Indeed, CTL generated in this manner exhibited anti-H-2Ld-specific reactivity, lysing both the H-2Ld and H-2L149 transfectants, while showing no lysis of syngeneic L cells ( Fig. 2A) .
Recognition of an H-2L Peptide by Crossreactive CTL. Since the CTL were selected on the basis of the crossreactivity between H-2Ld and H-2L149 products expressed on H-2k haplotype cells, we reasoned that these CTL might be capable of recognizing a peptide from the region common to both H-2L molecules-perhaps in association with H-2k restriction elements. To examine this possibility, we synthesized a peptide corresponding to amino acids 61-85 from the al domain of H-2Ld. This peptide was chosen because it is derived from a region shared by the two H-2L molecules, which is highly polymorphic among several other H-2 products. This region has been predicted to attain an a-helical conformation in class I molecules (17) , as recently confirmed by the crystal structure of the HLA-A2 molecule (18, 19) .
In fact, these CTL efficiently lysed syngeneic target cells in the presence of the H-2Ld-derived pentacosapeptide (Fig.  2B) . Lysis of C3H cells by these CTL appeared to be dependent on the sequence and conformation of the H-2Ld_ (61-85) pentacosapeptide because no killing was observed in the presence of a H-2Dd_(61-85) pentacosapeptide or of an analogue of the H-2d1(61-85) pentacosapeptide containing D-glutamine and D-leucine residues. In addition, two unrelated peptides, a T-cell receptor peptide and a class II peptide, were unable to mediate lysis by these CTL (data not shown). Interestingly, a population of anti-1591 CTL se-60 90
GTHTLQVHYGCDVGSDGRLLRGYEQFAYDGCDYIALNEDLKTVTAADHAAQI TRRKVEQAGAAEYYRAYLEGECVEVLHRYLKNGNATLLRT H-2L 149 lected in parallel for growth on an H-2L'49 L-cell transfectant instead of an H-2Ld transfectant failed to exhibit peptide-specific reactivity, although these cells retained reactivity with H-2Ld and H-2L'49 transfectants ( Fig. 2 C and D) . Therefore, selection for growth on an H-2Ld L-cell transfectant appears to be important for enrichment of the presumably small percentage of anti-H-2L CTL cells exhibiting peptide reactivity. Recognition of the H-2L Peptide Is MHC-Restricted. To determine whether the H-2Ld peptide recognition is MHCrestricted, we examined a large panel of tumor cells and spleen cell blasts bearing various MHC haplotypes for the ability to present this peptide to the H-2L-reactive anti-1591 CTL (Fig. 3) Anti-1591 CTL Recognize H-2Ld as an Independent Antigen. Because the anti-1591 CTL populations selected on the H-2Ld-transfected cells appeared to efficiently recognize the H-2Ld peptide in association with C3H L cells, it was of interest to determine whether these CTL were also reactive with H-2Ld products in the absence of H-2k haplotype restriction elements. In an attempt to select a peptide-reactive CTL population in the absence of the intact alloantigen, we grew anti-1591 CTL in the presence of untransfected L cells with the H-2Ld peptide for 8 weeks. These effectors were then used to determine whether the population of CTL that recognized the peptide were also able to lyse targets bearing intact H-2Ld (Fig. 4) . In fact, these cells also efficiently recognized H-2d haplotype P815 as well as BALB/c blast targets. Furthermore, lysis of BALB/c blasts was entirely dependent on the expression of an intact H-2Ld antigen, since BALB/c-H-2d'2 (Kd Dd) splenic blasts, which lack the H-2Ld product, were not lysed by the anti-peptide effectors and appeared to be unable to present the H-2Ld peptide. Therefore, the intact H-2Ld molecule functions either as a distinct antigenic target for the anti--2H2Ld effectors or alternatively functions as a restriction element presenting endogenous H-2Ld peptide to these CTL (see the Discussion).
Peptide Activation of H-2Ld-Specific CTL. The results described above suggest that the H-2Ld peptide in association with an H-2k restriction element mimics an antigenic determinant exhibited by the intact H-2Ld molecule. To determine whether this antigenic homology reflects structural conservation that might be detected by other CTL reactive with the H-2Ld antigen, we examined the ability of a panel of H-2Ld-reactive CTL clones to recognize the H-2Ld peptide. Three of the clones tested-L3, L9.4, and L13.D.4-lysed C3H L cells in the presence of the H-2Ld peptide (Fig. SA) . The fourth H-2Ld-reactive clone, L13.-D.8, appeared to exhibit no reactivity with C3H L cells in the presence of the H-2Ld peptide, indicating that, although this peptide appears to be an important antigenic determinant recognized by many H-2L-reactive CTL, other H-2L-reactive CTL appear to recognize distinct structures. These data were especially intriguing because two CTL, L3 and L9.4, were originally generated against target cells that do not express H-2k haplotype class I products (12, 13) . Furthermore, as with the recognition of the H-2Ld peptide by the anti-1591 effectors examined above, peptide recognition by the CTL clone L3 can be mediated by only H-2k restriction elements (Fig. SB) .
Together 1, 3) . In most cases, antigen recognition by T cells is MHC-restricted-i.e., individual T cells recognize antigen only in association with specific self-MHC products. Despite the structural differences between class I and class II antigens and their diverse biological functions, both classes of MHC antigens may share a common antigen-presentation mechanism. Recent experiments suggest that both class I and class II molecules present antigen to MHC-restricted T cells in the form of processed peptides (4, 6, 18, 19, (23) (24) (25) . Moreover, in one example, alloreactive T cells have been identified that appear to recognize class I peptides in association with class I restriction elements (11) . However, it is not yet clear whether all examples of T-cell recognition, in particular allorecognition, necessarily involve the presentation of antigenic peptides.
In this report, we attempt to define the structures recognized by H-2Ld-reactive CTL by using synthetic peptides homologous to the H-2Ld amino acid sequence. We find that H-2Ld-reactive CTL derived by several distinct protocols are able to recognize H-2Ld products either as a synthetic peptide in association with an H-2k restriction element or presumably as a native molecule expressed on allogeneic cells. As with CTL recognition of virus-derived peptides, recognition of the H-2Ld-derived peptide is MHC-restricted, apparently by H-2Dk. This suggests that the H-2Ld peptide in association with an H-2k restriction element mimics a T-cell epitope exhibited by the H-2Ld molecule.
Recent crystallographic analysis of HLA-A2 reveals that this class I molecule has an antigen-binding cleft comprised of two a helices on top of a ,-pleated sheet (18, 19) . One of the most interesting features of this structure is that the majority of the amino acid residues on the helices, which are polymorphic among various class I molecules, are oriented toward this cleft. As a result, the primary function of the polymorphic residues appears to be involved with antigen binding rather than interaction with the T-cell receptor per se. However, our results suggest that at least some of the polymorphic residues are directly recognized by the T-cell receptor because a peptide derived from the al helix can reconstitute the antigenic structure seen by alloreactive T cells on the intact molecule. Therefore, it might be necessary to postulate a class I conformation in which the polymorphic residues on the helix are more accessible for T-cell interaction. Such a conformation might be attained if the al helix were presented as a peptidic antigen by both the H-2Ld and H-2k haplotype restriction elements. In this model the peptide would be presented in an homologous spatial configuration by both restriction elements, consistent with the crossreactivity seen. Alternatively, residues mapping to the ahelix might, in fact, constitute part of the polymorphic structure of the intact H-2Ld molecule recognized by the alloreactive CTL. If so, the peptide derived from the H-2Ld helix might be able to displace the homologous a-helix of the H-2k restriction element and, therefore, regenerate an intact H-2Ld epitope.
The antigenic crossreactivity described in this report is analogous to that often observed for T cells specific for nominal antigens. Such antigen-specific self-MHC-restricted T cells frequently recognize alloantigenic MHC products (26) (27) (28) (29) . If alloreactivity frequently involves the recognition of processed MHC peptides in an MHC-dependent manner, it might be possible that the observed crossreactivity reflects structural homology between the nominal peptidic antigens and alloantigenic MHC peptides. In fact, since self-MHC peptides are probably also being presented during T-cell education in the thymus, structural homology to an MHC peptide might determine, in part, whether a given foreign peptide can elicit a T-cell response.
